Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Flurazepam hydrochloride
Drug ID BADD_D00940
Description A benzodiazepine derivative used mainly as a hypnotic.
Indications and Usage For short-term and intermittent use in patients with recurring insomnia and poor sleeping habits
Marketing Status approved; illicit; investigational
ATC Code N05CD01
DrugBank ID DB00690
KEGG ID D00695; D01408
MeSH ID D005479
PubChem ID 14434
TTD Drug ID D08XFV
NDC Product Code 48087-0021; 12828-0017
UNII 756RDM536M
Synonyms Flurazepam | Dalmane | Dalmadorm | Dormodor | Flurazepam Hydrochloride | Hydrochloride, Flurazepam | Flurazepam Dihydrochloride | Dihydrochloride, Flurazepam | Flurazepam Monohydrochloride | Monohydrochloride, Flurazepam | Staurodorm | Apo-Flurazepam | Apo Flurazepam | Flurazepam Mono-Perchlorate | Flurazepam Mono Perchlorate | Mono-Perchlorate, Flurazepam
Chemical Information
Molecular Formula C21H23ClFN3O.2ClH
CAS Registry Number 1172-18-5
SMILES CCN(CC)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F.Cl.Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hyperhidrosis08.01.03.028; 23.02.03.004--
Hypotension24.06.03.002--
Irritability08.01.03.011; 19.04.02.013--
Lethargy08.01.01.008; 17.02.04.003; 19.04.04.004--
Leukopenia01.02.02.001---
Logorrhoea17.02.08.006; 19.19.02.001---
Nausea07.01.07.001--
Nervousness19.06.02.003---
Pain08.01.08.004--
Palpitations02.11.04.012--
Pruritus23.03.12.001--
Rash23.03.13.001---
Restlessness17.02.05.021; 19.11.02.002--
Salivary hypersecretion07.06.01.009---
Sedation17.02.04.005---
Somnolence17.02.04.006; 19.02.05.003--
Syncope02.11.04.015; 17.02.04.008; 24.06.02.012--
Vision blurred06.02.06.007; 17.17.01.010--
Vomiting07.01.07.003--
Paradoxical drug reaction08.06.01.014---
Blood alkaline phosphatase increased13.04.02.004--
Genitourinary tract infection11.01.14.005; 20.08.02.003; 21.10.03.005---
Decreased appetite08.01.09.028; 14.03.01.005--
The 2th Page    First    Pre   2    Total 2 Pages